AVOPEF vs IMDELLTRA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. AVOPEF and IMDELLTRA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AVOPEF	IMDELLTRA
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ETOPOSIDE	TARLATAMAB-DLLE
Manufacturer	Avyxa Holdings	Amgen Inc
Dosage forms	Injectable	Kit
Drug class	Topoisomerase Inhibitor	—
Boxed warning	None	None
Treats	Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms	Lung Neoplasms

avopef imdelltra

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

ETOPOSIDE

TARLATAMAB-DLLE

Manufacturer

Avyxa Holdings

Amgen Inc

Dosage forms

Injectable

Kit

Drug class

Topoisomerase Inhibitor

—

Boxed warning

None

Treats

Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms

Lung Neoplasms

Frequently asked questions

What is the difference between Avopef and Imdelltra?

Avopef contains Etoposide, while Imdelltra contains Tarlatamab-Dlle — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.